COVID-19 trials registries data warehouse

https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=11053

Cheikh T. NDOUR

cheikh.ndour@ucad.edu.sn

2020-05-14

Not recruiting

RCT

Randomized

Parallel

Open label

single-center

Treatment

(i) patients above the age of 18 with PCR confirmed covid19 infection less than 72 hours prior to randomisation,, (ii) absence danger signs such as respiratory distress requiring mechanical ventilation or supplemental oxygen encephalitic disorders, renal function failure, (iii) absence of known chronic illness.

(i) Known allergy to any of the study medication, (ii) pregnancy or breastfeeding, (iii) ECG abnormality at admission, (iii) Patients with ALAT/ASAT higher than 3 times the upper limit of normal on admission, (iv) Patients with known chronic kidney diseases, (v) Patients with known retinal diseases.

3

Faculty of Medicine University Cheikh Anta Diop of Dakar Senegal.

19

64

Senegal

Mild/moderate disease at enrollment

2: Mild/moderate disease at enrollment

384

Percentage of patients with undetectable viral load 7 days after treatment initiation.

| Declared number of arm (3.0) differs from found arms (4.0)

Phase 3

[{"arm_notes": "", "treatment_id": 1534, "treatment_name": "Azithromycin+hydroxychloroquine", "treatment_type": "Antibiotics+antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1534, "treatment_name": "Azithromycin+hydroxychloroquine", "treatment_type": "Antibiotics+antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1397, "treatment_name": "Zinc", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}]